We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Survey in Patients With Chronic Adrenal Insufficiency in Germany

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00444119
First Posted: March 7, 2007
Last Update Posted: March 7, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Wuerzburg
  Purpose
The purpose of this survey is to assess patients with chronic primary or secondary adrenal failure regarding subjective health status, incidence and causes of adrenal crisis, hormone replacement regimens and concomitant endocrine or non endocrine disease.

Condition
Adrenal Insufficiency Addison's Disease

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Retrospective/Prospective

Resource links provided by NLM:


Further study details as provided by University of Wuerzburg:

Study Start Date: May 2004
Estimated Study Completion Date: April 2005
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age > 18 years
  • chronic adrenal failure with disease duration > 12 months and hormone replacement therapy for cortisol deficiency

Exclusion Criteria:

  • adrenal insufficiency due to adrenocortical carcinoma
  • AI due to long-term pharmacological glucocorticoid treatment
  • glucocortiocid doses above 7.5 mg prednisolone equivalent for other reasons than AI
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00444119


Locations
Germany
Dept of Medicine, Gastroenterology, Hepatology and Endocrinology, Charité Campus Mitte, Charité, University Medicine Berlin
Berlin, Germany, D-10117
University of Wuerzburg, Dept of Medicine - Endocrine and Diabetes unit
Wuerzburg, Germany, D-97080
Sponsors and Collaborators
University of Wuerzburg
Investigators
Principal Investigator: Bruno Allolio, MD University of Wuerzburg
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00444119     History of Changes
Other Study ID Numbers: Wü_NNRIS_45/04
First Submitted: March 5, 2007
First Posted: March 7, 2007
Last Update Posted: March 7, 2007
Last Verified: March 2007

Keywords provided by University of Wuerzburg:
adrenal insufficiency
subjective health status
quality of life
adrenal crisis
hormone replacement
DHEA

Additional relevant MeSH terms:
Adrenal Insufficiency
Addison Disease
Adrenal Gland Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases
Epinephrine
Racepinephrine
Epinephryl borate
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Adrenergic beta-Agonists
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Anti-Asthmatic Agents
Respiratory System Agents
Mydriatics
Sympathomimetics
Vasoconstrictor Agents